Fingerprint
Dive into the research topics of 'Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically